Member Info for Bufflehead1992

It needs test validation to move. Words and plans of AS have caused this all time low. We know if BB in US doesn't get a collaboration soon, CIZ will need another placing. Never mind staged payments in future. We hope BB and his rich backers can agree with a Co to produce a test soon.

4.8% holding on 15th March. Further stake building since. They can declare whenever they like. Buy now for long term gains.

Can I ask, if one direct competitor OBI which is already in US market is a concern to you?

Thanks BBN. Only one error. OBI have already entered US market, through trials in HCA hospitals. Steriwave is nasal photo disinfection prior to spinal surgery. It has very good safety data. However needs funding in my view. Not in either currently but watching with interest.

Nice 900K buy at end of day. Research results are a long way off but in the right place now. Funding is still needed for Nanogenics in my view. Hope its non dilutive. Apply for a grant NT.

Sorry to tell you 10.72p was final buy price of day. Those 2 x 1.6 Million trades look odd....

Collaboration with SRI in California. Research organisation will conjugate its MGS to Nuvec in order to increase intracellular delivery to specific target cells. Could be a way forward in US with major Pharmas adopting if successful.

Thanks for reply Mozaxs & Superda. Will try to research him later. Would be good to know if he bought in at recent lows, or averaging down from last year.

Anyone know who S Chari is ? Adding to holding recently. How long has he been invested ?

Could NT not even see how the RNS reads with U and S on different lines and many words on different lines which makes it look incompetent. If he had missed out " the " perhaps it would read better. Us shareholders have funded his long awaited collaboration and this will not generate cash. Pharma deal is not near term. Dissappointed with his wording and deal making. Years of near term no longer mean even one deal.

Price is a bargain I agree but if its lower tomorrow and next week why buy now ? Planiing to double my holding once the MOU done and funds received. This will come good as the Science works. Could be the best early lung cancer detection test yet, however without sales and US adopting tests it will be worth nothing.

I can sell 2-700K at 1.6380 with 800K dropping to 1.60 on Barclays. Tech did well to get all sold at 1.70 Which broker ? Daily movements are only lower until news in my view. May be wrong, as I was earlier.

Totally Wrong on sells today. Apologies. 260K shares sold and 5% drop of £6 Million Co value. Ha Ha.

I want communications with media as soon as the Lab developed test is released with data. Whether in 6 months or 12 months time. That will enable public to buy CIZ shares and share in the rewards. Not just benefit Lung cancer patients and oncologists.

The people who took part in placing will not buy to lower their averages. They know the timetable and a 15% drop in SP in a month on illiquid share, is not worth the worry. Once Lab developed test has been validated and data on accuracy released a few hundred percent rise is possible. AS needs to be doing interviews then.Sky, BBC and ITN and Press. If he fails on that, he is not performing any PR for a unique opportunity in UK Bio tech.

Obvious MM sells today. To collect cheap shares. News due and this is not just the £100K banked. Despite AS keeping all PI's in lock out with no news for 6 months, he has created a situation where Lab developed test can be completed without further raises and dilution. It all relies on Bill delivering funds from the sophisticated HNWI soon. They want in on this.

Just watched GDR Investor Meet Co (IMC)presentation. Funding needed. . 25% drop in SP in an hour. This would harm AS more than any other platform. Direct questions to not deflect with China. Another Lung Cancer detection Co LLAI is on IMC platform this afternoon at 4pm, free to use. They are using AI to help screen lung nodules that may not be cancerous. Some early data suggest 81% success. We need a test out this year. Or 1p will be the best we can hope for. It is all due to lack of trust. Very near term AS. In US Bill we hope for delivery of funds.

AS has not found a US Co to partner with, on acceptable terms to what he proposed. Hence Bill was clever enough to see the opportunity to try and set up a US Co and discuss the opportunity with his so called sophisticated HNWI, who he is asking to fund the next stages of developing the lab devloped test for US market. Fair enough Bill. Wise man.

What I find incredible is AS responding to a question about a test for UK market with the first country mentioned being China.

How can two £52K trades today go through at 1.80p when I could not even sell £10K the whole day.

Must be brokers, or else they were buys. But I tried a £7K buy after and Barclays would not allow it.

I predict that AS will avoid Investor Meet platform in future. He cannot avoid AGM. So I will be attending, as I hope you can Neil. We want the same outcome. An approved test ASAP

AS asked about plans for UK at 7mins 52 seconds. Answer took until 9 mins & 13 seconds with quote " for our strategy in China and putting those things in place in rest of Asia PAC and most importantly Europe and the UK " If that answers anything about plans for UK I fail to see how it did. So lab developed test will be in US over the coming months, with no revenue for at least 15 months. If all the clinical trials are a success and approved in US, we will still not have a UK test. The ambiguity of his answers is awe inspiring. We need an Investors Meet interview. We can agree on questions for him whether through Telegram group, of which I am not a member or by a poll on here. I am sure Neilin will help compose such a list of straightforward questions. Has he tried to approach ABDX or other UK Co to collaborate on a UK product launch ? So many of us are hoping the test is a success and are now relying on US HNWI and investors to fund it. Can Bill persuade enough of his contacts to fund his CIZ ? He will not tell us if he cannot.

AS was unable to negotiate a deal with BioTechne last year in my view. So to give him some credit he had to search for new backers and labs for supply. Which he has done discreetly without anyone being told. Bill on X alerted us to his excitement. Now he has the helm and we are reliant on him finding funding to start producing tests. This year would be a great result. At least with a Private Co in US, he can alert us about his success on X if he can find HNWI's. We are now awaiting the AS Investor Meet interview. Imagine just how believable he may sound. In the very near term AS.

Sold out to Bill of US. What on first reading seems a good RNS is proof that BioTechne are no longer involved. It stinks. AS could not tell shareholders they were holding him to ransom. They held all the aces. We only had the Science and IP. Which is why he denied shareholders that information. I understand his dilemma. (Situation involving a choice between two equally undesrirable alternatives) US MEGA CO get what they want or nothing.